Plus Therapeutics grants new CDO inducement awards: 20,000 options, 20,000 RSUs
PUBT · 04/22 20:36
Share
Listen to the news
- Plus Therapeutics granted inducement equity awards to new Chief Development Officer Eric J Daniels, effective April 20, 2026.
- Package included stock options for 20,000 shares with a 10-year term at an exercise price of $7.30.
- Award also included 20,000 restricted stock units that convert into common shares on vesting.
- Options vest over four years, starting with 25% on April 20, 2027.
- RSUs vest over three years, starting with one-third on first quarter date following April 20, 2027.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604221630PRIMZONEFULLFEED9694214) on April 22, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved